a new h2-receptor antagonist , nizatidine ( 150 mg h.s . ) , was compared with placebo as maintenance therapy in a randomized , parallel , double-blind , one-year study of 513 patients with recently healed duodenal ulcer .
C0085154
nizatidine
C0013295
duodenal ulcer